109 related articles for article (PubMed ID: 8633259)
1. Evaluation of rectal shielding in a Henschke system applicator.
Howlett SJ; Denham JW; Kron T
Strahlenther Onkol; 1996 May; 172(5):265-9. PubMed ID: 8633259
[TBL] [Abstract][Full Text] [Related]
2. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
[TBL] [Abstract][Full Text] [Related]
4. [Rectal shielding for a Selectron-ring applicator system (HDR- and LDR-afterloading)].
Hetzel H; Kamleitner H; McCoy M; Frommhold H
Strahlenther Onkol; 1987 Dec; 163(12):782-6. PubMed ID: 3424077
[TBL] [Abstract][Full Text] [Related]
5. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.
Shin KH; Huh SJ; Chie EK; Choi DR; Lim DH; Kim MK; Lee KC; Kim DY; Ahn YC
Radiat Med; 1999; 17(4):289-93. PubMed ID: 10510902
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
[TBL] [Abstract][Full Text] [Related]
7. Rectum dose analysis employing a multi-purpose brachytherapy phantom.
Huh H; Kim W; Loh JJ; Lee S; Kim CY; Lee S; Shin D; Shin D; Cho S; Jang J; Lim S; Cho KH; Kwon S; Kim S
Jpn J Clin Oncol; 2007 May; 37(5):391-8. PubMed ID: 17538010
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison of ring and ovoid applicators.
Tuncell N; Toy A; Demiral AN; Cetingoz R; Garipagaoglu M
J BUON; 2009; 14(3):451-5. PubMed ID: 19810138
[TBL] [Abstract][Full Text] [Related]
9. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer.
Gifford KA; Horton JL; Pelloski CE; Jhingran A; Court LE; Mourtada F; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):615-21. PubMed ID: 16168853
[TBL] [Abstract][Full Text] [Related]
10. [Dosimetry methods in determining radiation dosage of the rectum in HDR-brachytherapy of cervix carcinoma].
Eich HT; Haverkamp U; Micke O; Prott FJ; Pötter R
Strahlenther Onkol; 1998 Jul; 174(7):375-80. PubMed ID: 9689959
[TBL] [Abstract][Full Text] [Related]
11. An analysis of the effect of ovoid shields in a selectron-LDR cervical applicator on dose distributions in rectum and bladder.
Steggerda MJ; Moonen LM; Damen EM; Lebesque JV
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):237-45. PubMed ID: 9300759
[TBL] [Abstract][Full Text] [Related]
12. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging.
Price MJ; Jackson EF; Gifford KA; Eifel PJ; Mourtada F
Med Phys; 2009 Dec; 36(12):5515-24. PubMed ID: 20095264
[TBL] [Abstract][Full Text] [Related]
13. Influence of different Fletcher-Suit applicator geometries on sagittal dose distribution.
Palvolgyi J
Phys Med; 2010 Jan; 26(1):49-54. PubMed ID: 19386528
[TBL] [Abstract][Full Text] [Related]
14. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
Davidson MT; Yuen J; D'Souza DP; Batchelar DL
Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
[TBL] [Abstract][Full Text] [Related]
15. Screens in ovoids of a Selectron cervix applicator.
Meertens H; van der Laarse R
Radiother Oncol; 1985 Jan; 3(1):69-80. PubMed ID: 3975442
[TBL] [Abstract][Full Text] [Related]
16. High dose rate (HDR) brachytherapy technique: for carcinoma of uterine cervix using Nucletron applicators.
Nair MT; Cheng MC; Barker A; Rouse BS
Med Dosim; 1995; 20(3):201-7. PubMed ID: 7576095
[TBL] [Abstract][Full Text] [Related]
17. Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy.
Mikell JK; Klopp AH; Gonzalez GM; Kisling KD; Price MJ; Berner PA; Eifel PJ; Mourtada F
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e417-22. PubMed ID: 22436788
[TBL] [Abstract][Full Text] [Related]
18. Exploring the potential of mixed-source brachytherapy for the treatment of cervical cancer using high-dose rate 192Ir and/or 50 kV electronic sources.
Cohen DM; Hiatt JR; O'Connor B; Curran B; Sternick ES; Wazer DE
Brachytherapy; 2011; 10(2):141-6. PubMed ID: 20889390
[TBL] [Abstract][Full Text] [Related]
19. Geometrical sparing factors for the rectum and bladder in the prediction of grade 2 and higher complications after high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Yang SN; Lin FJ
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1335-43. PubMed ID: 19386443
[TBL] [Abstract][Full Text] [Related]
20. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]